This inventor holds 2 USPTO granted patents. Top assignees: Denka Company Limited, Hokkaido University, Kazuhiro Nouso. Active years: 2025-2026.
Company Filing History:
2 out of 385 
2 out of 442 
1 out of 1 
Years Active: 2025-2026
Title: Kazuhiro Nouso: Innovator in Nonalcoholic Steatohepatitis Detection
Introduction
Kazuhiro Nouso is a notable inventor based in Okayama, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the detection of nonalcoholic steatohepatitis (NASH). His innovative approach aims to provide less invasive methods for diagnosing this condition, which is increasingly relevant in today's healthcare landscape.
Latest Patents
Kazuhiro Nouso holds a patent for a method that aids in the detection of nonalcoholic steatohepatitis. This method is designed to assist in determining the degree of progression of conditions associated with NASH. It is far less invasive than traditional liver biopsy techniques and includes simple operations that do not depend on the skills of technicians. The invention involves measuring the abundance of LDL-TG and/or ApoE-rich HDL-C in a test blood sample isolated from a living body. This innovative method not only facilitates the detection of NASH but also helps in assessing related medical conditions such as fatty degeneration, inflammation, ballooning degeneration, and fibrosis.
Career Highlights
Throughout his career, Kazuhiro Nouso has worked with prominent organizations, including Denka Company Limited and Hokkaido University. His experience in these institutions has contributed to his expertise in medical research and innovation.
Collaborations
Kazuhiro has collaborated with notable colleagues such as Yasuki Ito and Motoko Ohta. Their combined efforts have further advanced the research and development of diagnostic methods for NASH.
Conclusion
Kazuhiro Nouso's contributions to the field of medical diagnostics, particularly in the detection of nonalcoholic steatohepatitis, highlight his innovative spirit and dedication to improving healthcare. His patent represents a significant step forward in providing less invasive diagnostic options for patients.